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See related research by Rodrigo et al., http://arthritis-research.com/content/15/6/R201, and
related letter by Sherry, http://arthritis-research.com/content/16/1/402We greatly appreciate Sherry’s comments [1] on our re-
cent article published in Arthritis Research & Therapy
[2], and we agree with him that, although the majority of
patients with celiac disease (CD) and fibromyalgia syn-
drome (FMS) may improve with a gluten-free diet
(GFD), this may not be a uniform phenomenon. How-
ever, we believe that his observations in children [3] can-
not be extrapolated to adults, such as those comprising
our target population.
Globally, the seven adult females with screening-
detected CD, also categorized in our series as patients
with severe irritable bowel syndrome (IBS) and FMS, sig-
nificantly improved after 1 year on a GFD, with a de-
crease of 51% to 60% in tender points, Fibromyalgia
Impact Questionnaire, Health Assessment Question-
naire, and visual analog scales as well as in the number
of drugs prescribed, accompanied by an increase of 48%
to 60% in Short-Form Health Survey (SF-36) physical
and mental scores and a reduction of tissue transgluta-
minase 2 to normal values [3]. However, we observed
that some important items of the SF-36 (including social
functioning, role emotional, and mental health) were al-
most unchanged. Therefore, although in general a sig-
nificant improvement was seen in all outcome measures
with CD treatment, the improvement was not uniform
but was much more obvious in some cases than in* Correspondence: lrodrigosaez@gmail.com
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© BioMed Central Ltd.2014others. The improvement was statistically significant but
always partial, since the total disappearance of all symp-
toms was not achieved by any of the patients [4].
Since treatment with a GFD is a reasonable and rela-
tively easy therapeutic measure that can significantly in-
crease the quality of life (though not entirely relieve
symptoms) of many patients with both FMS and CD, it
seems advisable in our opinion to investigate CD with
serology and genetic markers and, if these turn out to be
positive, to perform an upper gastrointestinal endoscopy
in conjunction with several duodenal biopsies. This will
enable the selection of patients with IBS and FMS who
are likely to respond to a GFD.
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